These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6967905)

  • 1. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells: characterization of the effector lymphocyte.
    Rola-Pleszczynski M
    J Immunol; 1980 Oct; 125(4):1475-80. PubMed ID: 6967905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells. Kinetics in normal donors and patients with recurrent herpes labialis.
    Rola-Pleszczynski M
    J Clin Lab Immunol; 1981 Jul; 6(1):39-43. PubMed ID: 7265173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
    Shore SL; Melewicz FM; Gordon DS
    J Immunol; 1977 Feb; 118(2):558-66. PubMed ID: 190316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte.
    Santoli D; Trinchieri G; Lief FS
    J Immunol; 1978 Aug; 121(2):526-31. PubMed ID: 681748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
    Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
    J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
    Welsh RM; Haspel MV; Parker DC; Holmes KV
    J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
    Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
    J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
    Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
    Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity.
    Carter VC; Schaffer PA; Tevethia SS
    J Immunol; 1981 May; 126(5):1655-60. PubMed ID: 6971309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocyte induction of non-T cell-mediated nonspecific cytotoxicity. I. Introduction mechanisms.
    Mackler BF; O'Neill PA; Meistrich M
    Eur J Immunol; 1977 Feb; 7(2):55-61. PubMed ID: 326561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
    Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
    J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human peripheral null lymphocytes. II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus and Corynebacterium parvum.
    Peter HH; Dallügge H; Zawatzky R; Euler S; Leibold W; Kirchner H
    Eur J Immunol; 1980 Jul; 10(7):547-55. PubMed ID: 6157543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.
    Santoli D; Trinchieri G; Koprowski H
    J Immunol; 1978 Aug; 121(2):532-8. PubMed ID: 150448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: characterization of the effector cells.
    Tilden AB; Cauda R; Grossi CE; Balch CM; Lakeman AD; Whitley RJ
    J Immunol; 1986 Jun; 136(11):4243-8. PubMed ID: 3009620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of interleukin-2 and gamma globulin on immune dysfunction in a patient with severe mucocutaneous herpes simplex virus infection.
    Wise SL; Yarbrough JA; Stafford CT; Leffell MS; Thompson WO; Ades EW
    Ann Allergy; 1992 Jan; 68(1):47-52. PubMed ID: 1371040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes.
    Maccario R; Revello MG; Comoli P; Montagna D; Locatelli F; Gerna G
    J Immunol; 1993 Feb; 150(4):1437-45. PubMed ID: 8381835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
    J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interferon in human natural killer activity against target cells infected with HSV-1.
    Bishop GA; Glorioso JC; Schwartz SA
    J Immunol; 1983 Oct; 131(4):1849-53. PubMed ID: 6194217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.